Sexually transmitted infections (STIs) can be caused by bacteria (e.g. Treponema pallidum, Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma), viruses (e.g. HSV) or parasites (Trichomonas vaginalis), which are transmitted from person to person by vaginal, anal or oral sex. The course, symptoms and consequences of STIs can differ significantly depending on the causative pathogen. In many cases, the infection is asymptomatic, so that it remains undiscovered for a long time and is only diagnosed when it has become chronic.
For Research Use Only. Not For Use In Diagnostic Procedures.
The individual product regulatory statements may vary, please refer to the instructions for use for more information.
wdt_ID | Method | Parameter | Substrate | Species/ Antigen |
---|---|---|---|---|
682 | IFA | antibodies against Treponema pallidum unspecific FTA IgG positive control |
||
683 | IFA | antibodies against Treponema pallidum unspecific FTA IgM positive control |
||
684 | IFA | Treponema pallidum (FTA-ABS) |
bacterial smear verification BIOCHIP (2 BIOCHIPs per field) |
|
685 | IFA | Treponema pallidum FTA negative control |
||
686 | ELISA | Treponema pallidum | antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
687 | ELISA | Treponema pallidum incl. IgG/RF absorbent |
antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
688 | ELISA | Treponema pallidum Screen ELISA |
antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
689 | EUROLINE | positive control serum: IgG, human, 50x concentrated for Treponema pallidum |
||
690 | EUROLINE | positive control serum: IgM, human, 50x concentrated for Treponema pallidum |
||
691 | EUROLINE | Treponema pallidum (TpN15, TpN17, TmpA, TpN47 separately) |
||
692 | WESTERNBLOT | antibodies against Treponema pallidum IgG positive control |
||
693 | WESTERNBLOT | antibodies against Treponema pallidum IgM positive control |
||
694 | WESTERNBLOT | Treponema pallidum | Westernblot | 15 kDa, 17 kDa, 45 kDa (tmpA), 47 kDa |
695 | IFA | antibodies against Treponema pallidum IgG positive control for FTA absorption |
||
696 | WESTERNBLOT | EUROLINE-WB Treponema pallidum plus cardiolipin |
Westernblot | 15 kDa, 17 kDa, 45 kDa (tmpA), 47 kDa plus purified cardiolipin |
697 | ELISA | CSQ pair of controls anti-Treponema pallidum (IgG) |
||
698 | ELISA | Treponema pallidum antibody determination in CSF |
antigen-coated microplate wells |
recombinant antigens 15 kDa, 17 kDa, 47 kDa, 42 kDa (TmpA) |
699 | IFA | Treponema pallidum (FTA-ABS) |
bacterial smears verification BIOCHIP (3 BIOCHIPs per field) |
T. pallidum T. phagedenis |
700 | IFA | antibodies against Chlamydia trachomatis IgA positive control |
||
701 | IFA | antibodies against Chlamydia trachomatis IgG positive control |
||
702 | IFA | antibodies against Chlamydia trachomatis IgM positive control |
||
703 | IFA | Chlamydia trachomatis |
infected cells | EU 40 |
704 | ELISA | Chlamydia trachomatis | antigen-coated microplate wells |
native MOMP antigen from C. trachomatis |
705 | ELISA | Chlamydia trachomatis | antigen-coated microplate wells |
native MOMP antigen from C. trachomatis |
706 | ELISA | Chlamydia trachomatis incl. IgG/RF absorbent |
antigen-coated microplate wells |
native MOMP antigen from C. trachomatis |
2024 EUROIMMUN US
Privacy Policy | Website Terms and Conditions | Cookie Notice and Settings | Consent Preferences | Sitemap